SCN industry partner, Morphocell Technologies, secures US$40M in Series A financing to advance ReLiver®, an innovative cell therapy for liver disease April 4, 2024 12:20 pm Published by Trang Comments Off on SCN industry partner, Morphocell Technologies, secures US$40M in Series A financing to advance ReLiver®, an innovative cell therapy for liver disease
